Global Journal of Cancer Therapy Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Email: [email protected]
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Tsuyoshi Shirakawa

    Tsuyoshi Shirakawa
    Kyushu University, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
    Email: [email protected]
    Tel: +81-92-661-5395
    Fax: +81-955-70-1511

    More Info.


    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Editorial Board

    Ryou-U Takahashi
    Division of Molecular and Cellular Medicine
    National Cancer Center Research Institute
    Japan
    GJCT

    Research Interest: Molecular And Cell Biology, Microrna, Breast Cancer, Cancer Stem Cells


    More Info.
    Hidenari Nagai
    Department of Internal Medicine
    Toho University
    Japan
    GJCT

    Research Interest:  I Am Interested In Strategy Of Hepatocellular Carcinoma And Especially I Am Interested In Host Immunity In Patients With Liver Cirrhosis And Hepatocellular Carcinoma.


    More Info.
    Grivas Nikolaos
    Associate Member of EAU
    University of Ioannina
    Greece
    GJCT

    Research Interest: Bladder Cancer, Prostate Cancer, Renal Cancer, Urolithiasis And Uro-Gynaecology.

    More Info.
    Wei Du
    Hematology and Cancer Biology
    Cincinnati Childrens Hospital Medical Center
    USA
    GJCT

    Research Interest: Stem Cell Biology And Pathophysiology Of Bone Marrow Failure And Leukemia; Identifying And Targeting The Alternative Oxidative DNA-Damage Response Pathways Required For Cancer Progression; The Role Of A Major Proliferating Protein, Nucleophosmin (NPM) In Cancer Development


    More Info.
    Christopher Xin Jie Wong
    Centre for Heart Rhythm Disorders
    Royal Adelaide Hospital
    South Australia
    GJCT
    Research Interest: Dr Wong’s Research Interests Focus On The Mechanisms, Clinical Treatment And Public Health Implications Of Cardiovascular Disease.
    More Info.
    Raj Kumar Koiri
    Assistant Professor
    Department of Zoology
    Dr. Hari Singh Gour Central University
    India
    GJCT

    Research Interest: To study the metabolic adaptation for survival occurring in the cancer cells

    More Info.
    Athanasios Papatsoris
    Urology
    Royal London Hospital
    UK
    GJCT


    Research Interest: Endourology, Lithiasis, Laparoscopy, Prostate Cancer.

    More Info.
    Francisco Torrens
    Associated Professor
    Deparmenr of Biochemistry & Molecular Biology
    Universidad de Murcia,
    Spain
    GJCT

    Research Interest: Theoretical Chemistry, Physical Chemistry, Mathematical Chemistry, Computational Chemistry, Molecular Modelling, Simulation, And Design, Computer-Aided Drug Design And Development, Molecular Graphics And Representation Of Molecular Properties.


    More Info.
    Hua Yang
    Department of Cell Biology
    Peking University,
    China
    GJCT

    Research Interest: Oncology,including basic and clinical


    More Info.
    Julius Strauss
    Associate Investigator
    National Cancer Institute
    Thomas Aquinas College
    USA
    GJCT

    Research Interest: Cancer Immunotherapies  Therapeutic Cancer Vaccines, Genitourinary Malignancies

    More Info.
    Jose Maria Pereira de Godoy
    Assistant Professor
    Regional Medical School
    egional Medical School, São José do Rio Preto
    Brazil
    GJCT
    Research Interest: Breast CancerRehabilitationLymphedema  
    More Info.
    Stefania Staibano
    Professor
    Department of Pathology
    University of Naples Federico II
    Italy
    GJCT

    Research Interest: Head And Neck Pathology Section At The Department Of Surgical Pathology


    More Info.
    Xingding Zhang
    Assistant Professor
    Diagnosis and Nanomedicine Engineering Technology Center
    China
    GJCT

    Research Interest: Autophagy and Apoptosis


    More Info.
    Maryam Azimi Mohammadabadi
    Department of Immunology
    Tehran University of Medical Science
    Iran
    GJCT

    Research Interest: Potential Therapeutic Applications of Arteether, a Semi-Synthetized Derivative of Artemisinin on a Murine Model of Breast Cancer. As a Result, I Have Got Some Experience Atan Area of Tumor Immunology/Immunotherapynamed "Chemoimmunotherapy". Chemoimmunotherapy is an Approach for the Treatment of Cancers in Whichthe Focus is to enhance the Efficacy of chemotherapeutic Agents by Concomitant Application of Compounds with Immunomodulatory Properties. Besides my Thesis Work, I Managed to Do a Course in Cellular Immunology with Professor Hassan, One of the Well-Knownimmunologists in Iran, so that i could also Work on Cellular Immunology Aspects of Tumors. Moreover, Considering the Reported Associations between Molecular Players such as CTLA-4, PDL-1 and also Different Micrornas in Tumor Progression, i am Currently Planning to further Study these Associations in order to improve the Efficacy of Tumor Immunotherapy

    More Info.
    Tsuyoshi Shirakawa
    Department of Oncology
    Miyazaki University Hospital
    Japan
    GJCT

    Research Interest: Medical Oncology (Mainly Gastrointestinal Cancer), Cancer Stem Cell, Palliative Medicine,Multi-Disciplinary Coordination And Multi-Disciplinary Study


    More Info.
    View more
    mendeley

    Beyond Troponins: Emerging Biomarkers for Early Detection of Chemotherapy-Induced Cardiotoxicity in Breast Cancer

    DOI Logo 10.17352/2581-5407.000056

    Published On: May 29, 2026 | Pages: 004 - 019

    Author(s): Themelidi Vasiliki*, Vlachou Maria, Varvarelis Orfeas-Petros, Ioakeim Kalliopi, Kampouroglou Effrosyni and Tsekoura Dorothea
    Abstract View Full Article View
    mendeley

    The Impact of Positive Thinking on Disease Progression in Oncology Patients

    DOI Logo 10.17352/2581-5407.000055

    Published On: January 13, 2026 | Pages: 001 - 003

    Author(s): Ivan Milosevic*
    Abstract View Full Article View
    mendeley

    Analysis and Control of Oncolytic Virotherapy Dynamic Models

    DOI Logo 10.17352/2581-5407.000054

    Published On: August 14, 2025 | Pages: 001 - 009

    Author(s): Lakshmi N Sridhar*
    Abstract View Full Article View
    mendeley

    ANXA2 Enhances the Malignancy of Gastric Cancer Cells by Remodeling Cytoskeleton

    DOI Logo 10.17352/2581-5407.000053

    Published On: October 23, 2024 | Pages: 001 - 008

    Author(s): Yujuan Zhou, Wanlin Che, Xue Bai, Danying Zhang, Wenxuan Zhang, Hongming Fang, Guochao Nie* and Yingchun Hou*
    Abstract View Full Article View
    mendeley

    Understand the chronic pain!

    DOI Logo 10.17352/2581-5407.000052

    Published On: May 08, 2024 | Pages: 001 - 002

    Author(s): Essam Abdelrazek*
    Abstract View Full Article View
    mendeley

    Melanoma and basal cell carcinoma: Mimickers of each other

    DOI Logo 10.17352/2581-5407.000051

    Published On: September 23, 2023 | Pages: 020 - 022

    Author(s): Gustavo de Sá Menezes Carvalho*, Isabella N Dana, Juliana Casagrande Tavoloni Braga and Ashfaq A Marghoob

    ORCID Logo  0000-0002-4556-1763

    Abstract View Full Article View
    mendeley

    Flawed foundation is the root cause of failure of medicine and precludes cures for chronic diseases

    DOI Logo 10.17352/2581-5407.000050

    Published On: September 15, 2023 | Pages: 001 - 019

    Author(s): Jianqing Wu* and Ping Zha
    Abstract View Full Article View
    mendeley

    New modalities of surgery for renal tumors in children: A Mini-Review

    DOI Logo 10.17352/2581-5407.000049

    Published On: November 29, 2022 | Pages: 051 - 052

    Author(s): Jan Godzinski*
    Abstract View Full Article View    
    mendeley

    Investigation of the effectiveness of ECOLAB ’Drape ArmourTM’ Radiation Protection in limiting eye-lens doses of healthcare personnel exposed to ionizing radiation during gastroenterology - interventional radiology procedures

    DOI Logo 10.17352/2581-5407.000048

    Published On: October 20, 2022 | Pages: 046 - 050

    Author(s): Fulvio IM Fucilli*, Giuseppe Di Giovanni, Alessandro Mastrorocco, Matteo Ninni, Piero Loprete, Isa De Crudis, Massimiliano Marano, Antonio Santomauro and Fabio Fucilli

    ORCID Logo  0000-0002-1132-0363

    Abstract View Full Article View
    mendeley

    The effects of thymoquinone and cytozine arabinoside on apoptosis and cell proliferation in acute myeloide leukemia

    DOI Logo 10.17352/2581-5407.000047

    Published On: October 11, 2022 | Pages: 040 - 045

    Author(s): Aslı Altun, Nurten Kara, Şengül Tural*, Alişan Yıldıran and Leman Tomak

    ORCID Logo  0000-0002-8946-8165

    Abstract View Full Article View    

     

    Indexing/Archiving